These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5455025)

  • 1. [Influence of nicotinic acid therapy on liver steatosis].
    Kubasta M; Jezdinská V; Vaverková H; Vrána J; Zmeskal A; Nizník J
    Cesk Gastroenterol Vyz; 1970 Jul; 24(5):200-5. PubMed ID: 5455025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with nicotinic acid of patients with ischemic heart disease and hypercholesterolemia. II. Influence on the liver].
    Kubasta M; Nizník J; Jezdinská V; Vrána J; Vaverková H; Podivínský R; Zmeskal A
    Vnitr Lek; 1971 Feb; 17(2):154-62. PubMed ID: 5546846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with Metabolan in the therapy of fatty liver].
    Meigen B; Fallen H
    Z Allgemeinmed; 1973 Feb; 49(4):177-82. PubMed ID: 4701310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arteriosclerosis--nicotinic acid therapy. 9. Treatment of hypercholesteremia].
    Selvaag O
    Lakartidningen; 1971 Apr; 68(15):1768. PubMed ID: 5577251
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of nicotinic acid on serum & hepatic lipids in experimentally induced fatty liver.
    Vaishwanar I; Jiddewar GG; Shukla RD; Kowale CN
    Indian J Exp Biol; 1972 Nov; 10(6):428-30. PubMed ID: 4665440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Control of hyperlipemia and fatty liver degeneration with tetranicotylfructose].
    Zeller W
    Praxis; 1966 Nov; 55(44):1273-6. PubMed ID: 6013613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hyperlipemia and steatosis by high doses of meso-insitol hexanicotinate].
    Neuman M; Cachin M; Galian P; Charbonnier A; Pergola F
    Sem Ther; 1968 Dec; 44(10):660-3. PubMed ID: 5706294
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of arteriosclerosis with permanently administered large doses of nicotinic acid].
    Hermann B; Tornóczky J
    Z Arztl Fortbild (Jena); 1967 Jan; 61(2):77-81. PubMed ID: 5590807
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of fatty liver].
    Müting D
    Clin Ter; 1974; 70(2):5-6. PubMed ID: 4411261
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of cyclonicate in atherosclerotic coronary arteriopathy].
    Alvisi V; Strozzi C
    Minerva Cardioangiol; 1982 Apr; 30(4):209-11. PubMed ID: 7088305
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative evaluation of treatment of patients with coronary atherosclerosis with nicatol and nicotinic acid].
    Ivanchenko FT
    Vrach Delo; 1967 Jan; 1():76-80. PubMed ID: 4895148
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Nicotinic Acid, ascorbic acid and 1-triiodothyronine on serum and liver cholesterol levels.
    Tantengco VO; Canlas BD; Somera LC; Hcredo E
    Acta Med Philipp; 1966; 3(1):1-12. PubMed ID: 5975614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of hepatic steatosis].
    Filippini L
    Minerva Med; 1972 Apr; 63(31):1815-7. PubMed ID: 5025181
    [No Abstract]   [Full Text] [Related]  

  • 14. Fine structural changes in the liver in hypercholesteremic patients receiving long-term nicotinic acid therapy.
    Baggenstoss AH; Christensen NA; Berge KG; Baldus WP; Spiekerman RE; Ellefson RD
    Mayo Clin Proc; 1967 Jul; 42(7):385-99. PubMed ID: 6028334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical assessment of Cardilan].
    Markiewicz M; Korolko A
    Pol Tyg Lek; 1970 Nov; 25(47):1816-7. PubMed ID: 5484526
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination of a nicotinic acid derivative (N-oxide of pyridine-3-carboxylic acid) with vasotropic vitamins in hypocholesterolemic therapy].
    Tinti P; Contini P; Bonini M
    G Gerontol; 1965 Dec; 13(12):1431-9. PubMed ID: 5880982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-experimental studies on decreasing blood lipids in geriatrics].
    Bracharz H; Laas H
    Med Monatsschr; 1966 Oct; 20(10):471-6. PubMed ID: 5978465
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of aluminum nicotinate in the long-term reduction of serum cholesterol.
    McCabe ES
    Del Med J; 1966 Feb; 38(2):49-52. PubMed ID: 5906289
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the influence of a mesoinosite hexanicotinic acid ester on the lipolysis and carbohydrate metabolism].
    Hammerl H; Kränzl C; Pichter O; Studlar M
    Wien Klin Wochenschr; 1968 Apr; 80(14):269-71. PubMed ID: 5697957
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA
    Lakartidningen; 1971 Apr; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.